Synthesis and anticancer activity evaluation of new 1,2,3-triazole-4-carboxamide derivatives

Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines

Anne Monks, Dominic A. Scudiero, Philip Skehan et al. · JNCI Journal of the National Cancer Institute · 1991 · 3.2K citations

Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen

Michael R. Boyd, Kenneth D. Paull · Drug Development Research · 1995 · 1.5K citations

Chemoprevention Strategy, Cancer Biology, United States +21

An Information-Intensive Approach to the Molecular Pharmacology of Cancer

John N. Weinstein, Timothy G. Myers, P M O'Connor et al. · Science · 1997 · 1.2K citations

Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm

Kenneth D. Paull, Robert H. Shoemaker, Louis Hodes et al. · JNCI Journal of the National Cancer Institute · 1989 · 960 citations

1,2,3-Triazole-[2,5-Bis-O-(tert-butyldimethylsilyl)-.beta.-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole 2'',2''-dioxide) (TSAO) Analogs: Synthesis and Anti-HIV-1 Activity

Rosa Álvarez, Sonsoles Velázquez, Ana San‐Félix et al. · Journal of Medicinal Chemistry · 1994 · 746 citations